164 related articles for article (PubMed ID: 29399397)
21. Differential expression of the human MIXL1 gene product in non-Hodgkin and Hodgkin lymphomas.
Drakos E; Rassidakis GZ; Leventaki V; Guo W; Medeiros LJ; Nagarajan L
Hum Pathol; 2007 Mar; 38(3):500-7. PubMed ID: 17303500
[TBL] [Abstract][Full Text] [Related]
22. Proliferation of non-Hodgkin-lymphoma lymphocytes in vitro is dependent upon follicular dendritic cell interactions.
Petrasch S; Kosco M; Perez-Alvarez C; Schmitz J; Brittinger G
Br J Haematol; 1992 Jan; 80(1):21-6. PubMed ID: 1536807
[TBL] [Abstract][Full Text] [Related]
23. Tumor microenvironment in diffuse large B-cell lymphoma: Matrixmetalloproteinases activation is mediated by osteopontin overexpression.
Malaponte G; Hafsi S; Polesel J; Castellano G; Spessotto P; Guarneri C; Canevari S; Signorelli SS; McCubrey JA; Libra M
Biochim Biophys Acta; 2016 Mar; 1863(3):483-489. PubMed ID: 26381542
[TBL] [Abstract][Full Text] [Related]
24. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
[TBL] [Abstract][Full Text] [Related]
25. Mass Cytometry of Follicular Lymphoma Tumors Reveals Intrinsic Heterogeneity in Proteins Including HLA-DR and a Deficit in Nonmalignant Plasmablast and Germinal Center B-Cell Populations.
Wogsland CE; Greenplate AR; Kolstad A; Myklebust JH; Irish JM; Huse K
Cytometry B Clin Cytom; 2017 Jan; 92(1):79-87. PubMed ID: 27933753
[TBL] [Abstract][Full Text] [Related]
26. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
Huber H; Gattringer C; Thaler J; Peschel C
Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
[TBL] [Abstract][Full Text] [Related]
27. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
[TBL] [Abstract][Full Text] [Related]
28. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical analysis indicates that the anatomical location of B-cell non-Hodgkin's lymphoma is determined by differentially expressed chemokine receptors, sphingosine-1-phosphate receptors and integrins.
Middle S; Coupland SE; Taktak A; Kidgell V; Slupsky JR; Pettitt AR; Till KJ
Exp Hematol Oncol; 2015; 4():10. PubMed ID: 25938000
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression of basic fibroblast growth factor, vascular endothelial growth factor, and their receptors in stage IV non-Hodgkin lymphoma.
Ho CL; Sheu LF; Li CY
Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):316-21. PubMed ID: 12607599
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma.
Afonso J; Pinto T; Simões-Sousa S; Schmitt F; Longatto-Filho A; Pinheiro C; Marques H; Baltazar F
Cell Oncol (Dordr); 2019 Jun; 42(3):303-318. PubMed ID: 30790227
[TBL] [Abstract][Full Text] [Related]
32. BAFF-R is expressed on B-cell lymphomas depending on their origin, and is related to proliferation index of nodal diffuse large B-cell lymphomas.
Takahata H; Ohara N; Ichimura K; Tanaka T; Sato Y; Morito T; Takata K; Kojima M; Kobata T; Yoshino T
J Clin Exp Hematop; 2010; 50(2):121-7. PubMed ID: 21123970
[TBL] [Abstract][Full Text] [Related]
33. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
34. Distribution and ZAP-70 expression of WHO lymphoma categories in Shanxi, China: a review of 447 cases using a tissue microarray technique.
Wang J; Young L; Win W; Taylor CR
Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):323-32. PubMed ID: 16280661
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Acta Pharmacol Sin; 2006 Nov; 27(11):1438-46. PubMed ID: 17049119
[TBL] [Abstract][Full Text] [Related]
36. T follicular helper cells: a potential therapeutic target in follicular lymphoma.
Ochando J; Braza MS
Oncotarget; 2017 Dec; 8(67):112116-112131. PubMed ID: 29340116
[TBL] [Abstract][Full Text] [Related]
37. The role of cytokines in the pathogenesis and management of AIDS-related lymphomas.
Fassone L; Gaidano G; Ariatti C; Vivenza D; Capello D; Gloghini A; Cilia AM; Buonaiuto D; Rossi D; Pastore C; Carbone A; Saglio G
Leuk Lymphoma; 2000 Aug; 38(5-6):481-8. PubMed ID: 10953968
[TBL] [Abstract][Full Text] [Related]
38. Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders.
Sebti Y; Le Maux A; Gros F; De Guibert S; Pangault C; Rouas-Freiss N; Bernard M; Amiot L
Br J Haematol; 2007 Jul; 138(2):202-12. PubMed ID: 17593027
[TBL] [Abstract][Full Text] [Related]
39. Density of intranodal lymphatics and VEGF-C expression in B-cell lymphoma and reactive lymph nodes.
Wróel T; Mazur G; Dziegiel P; Jeleń M; Szuba A; Kuliczkowski K; Zabel M
Folia Histochem Cytobiol; 2006; 44(1):43-7. PubMed ID: 16584091
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 21 - its potential role in the therapy of B-cell lymphomas.
Bhatt S; Sarosiek KA; Lossos IS
Leuk Lymphoma; 2017 Jan; 58(1):17-29. PubMed ID: 27405876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
